We are live on ! Find out more
GJIC

Gamble Jones Investment Counsel Portfolio holdings

AUM $1.33B
1-Year Est. Return 11.55%
This Fund
S&P 500
This Quarter Est. Return
+3.19%
1 Year Est. Return
-11.55%
3 Year Est. Return
+32.88%
5 Year Est. Return
+72.75%
10 Year Est. Return
AUM
$918M
AUM Growth
+$17.9M
Cap. Flow
-$6.57M
Cap. Flow %
-0.72%
Top 10 Hldgs %
48.72%
Holding
210
New
7
Increased
65
Reduced
104
Closed
4

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$3.49M
2
DLTR icon
Dollar Tree
DLTR
+$2.16M
3
AAPL icon
Apple
AAPL
+$2.04M
4
PG icon
Procter & Gamble
PG
+$1.57M
5
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$1.24M

Sector Composition

Rank Sector Weight
1 Consumer Staples 37.54%
2 Healthcare 13.29%
3 Technology 9.66%
4 Industrials 9.01%
5 Financials 7.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PG icon
1
Procter & Gamble
PG
$338B
$257M 28%
3,035,801
-19,135
-0.6% -$1.57M
JNJ icon
2
Johnson & Johnson
JNJ
$619B
$30.5M 3.32%
251,361
-2,801
-1% -$318K
XOM icon
3
ExxonMobil
XOM
$636B
$28.9M 3.15%
308,033
-2,597
-0.8% -$230K
AAPL icon
4
Apple
AAPL
$4.55T
$23M 2.51%
964,412
-82,176
-8% -$2.04M
MSFT icon
5
Microsoft
MSFT
$3.73T
$22.4M 2.44%
437,564
-20,625
-5% -$1.07M
MMM icon
6
3M
MMM
$94.2B
$20.3M 2.21%
138,856
-1,209
-0.9% -$170K
PFE icon
7
Pfizer
PFE
$151B
$20.1M 2.19%
601,993
-88
-0% -$2.81K
BRK.B icon
8
Berkshire Hathaway Class B
BRK.B
$1.12T
$16.9M 1.85%
117,051
-2,380
-2% -$340K
ABBV icon
9
AbbVie
ABBV
$432B
$14.6M 1.59%
235,222
-57,233
-20% -$3.49M
ABT icon
10
Abbott
ABT
$186B
$13.5M 1.47%
342,585
+5,862
+2% +$233K
CVX icon
11
Chevron
CVX
$368B
$13.1M 1.43%
124,955
+315
+0.3% +$31.7K
GE icon
12
GE Aerospace
GE
$383B
$12.8M 1.39%
84,647
-2,003
-2% -$292K
PEP icon
13
PepsiCo
PEP
$189B
$12.3M 1.34%
116,267
+1,208
+1% +$125K
PM icon
14
Philip Morris
PM
$295B
$12.1M 1.32%
118,835
-1,683
-1% -$168K
SLB icon
15
SLB Ltd
SLB
$76B
$10.6M 1.15%
133,529
+2,606
+2% +$200K
INTC icon
16
Intel
INTC
$507B
$9.99M 1.09%
304,670
-14,976
-5% -$469K
NVS icon
17
Novartis
NVS
$297B
$9.68M 1.05%
130,868
+54,467
+71% +$3.76M
DLTR icon
18
Dollar Tree
DLTR
$25.1B
$9.48M 1.03%
100,633
-25,485
-20% -$2.16M
BMY icon
19
Bristol-Myers Squibb
BMY
$131B
$9.09M 0.99%
123,538
-1,700
-1% -$120K
VZ icon
20
Verizon
VZ
$195B
$8.9M 0.97%
159,379
+4,507
+3% +$234K
GOOGL icon
21
Alphabet (Google) Class A
GOOGL
$4.34T
$8.77M 0.96%
249,400
-4,280
-2% -$157K
TXN icon
22
Texas Instruments
TXN
$259B
$8.73M 0.95%
139,298
-3,580
-3% -$213K
WFC icon
23
Wells Fargo
WFC
$262B
$8.49M 0.93%
179,439
+3,572
+2% +$174K
GOOG icon
24
Alphabet (Google) Class C
GOOG
$4.32T
$8.46M 0.92%
244,340
-7,880
-3% -$283K
MA icon
25
Mastercard
MA
$495B
$8.28M 0.9%
94,008
-1,770
-2% -$169K

Similar funds

Gamble Jones Investment Counsel's Q2 2016 Portfolio in Review

As of Q2 2016, Gamble Jones Investment Counsel held 210 positions worth $918M, up 2% from $900M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Gamble Jones Investment Counsel's Q2 2016 filing shows 7 new, 65 increased, 104 reduced and 4 closed positions. Its largest new stake was SS&C Technologies: 57,912 shares worth $1.63M. The largest sale was AbbVie, an estimated $3.49M.

By sector, the portfolio is most concentrated in Consumer Staples at 38% of assets, up from 37% a quarter earlier, followed by Healthcare and Technology.

  • Gamble Jones Investment Counsel's largest Q2 2016 buy was SS&C Technologies: 57,912 shares worth $1.63M.
  • Gamble Jones Investment Counsel added most to Novartis in Q2 2016, an estimated $3.76M increase.
  • Gamble Jones Investment Counsel's biggest Q2 2016 reduction was AbbVie, cutting an estimated $3.49M.
  • Gamble Jones Investment Counsel fully exited Allergan Inc in Q2 2016, selling an estimated $348K.
  • Gamble Jones Investment Counsel's ten largest holdings make up 49% of its $918M portfolio in Q2 2016.
  • Gamble Jones Investment Counsel opened 7 new positions and closed 4 in Q2 2016.
  • Gamble Jones Investment Counsel's portfolio value rose 2% quarter-over-quarter to $918M.

Based on Gamble Jones Investment Counsel's 13F filing for Q2 2016, filed 9 Aug 2016.